Literature DB >> 15752764

Crystal structure of recombinant human growth and differentiation factor 5: evidence for interaction of the type I and type II receptor-binding sites.

Herman Schreuder1, Alexander Liesum, Jens Pohl, Michael Kruse, Masayoshi Koyama.   

Abstract

The crystal structure of human growth differentiation factor 5 (GDF5) was solved at 2.4A resolution. The structure is very similar to the structure of bone morphogenetic factor 7 (BMP7) and consists of two banana-shaped monomers, linked via a disulfide bridge. The crystal packing of GDF5 is the same as the crystal packing of BMP7. This is highly unusual since only 25-30% of the crystal contacts involve identical residues. Analysis of the crystal packing revealed that residues of the type I receptor epitope are binding to residues of the type II receptor-binding epitope. The fact that for both BMP family members the type I and type II receptor-binding sites interact suggests that the complementary sites on the receptors may interact as well, suggesting a way how preformed receptor heterodimers may form, similar to the preformed receptors observed for the erythropoietin receptor and the BMP2 receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752764     DOI: 10.1016/j.bbrc.2005.02.078

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation.

Authors:  Vaclav Veverka; Alistair J Henry; Patrick M Slocombe; Andrew Ventom; Barbara Mulloy; Frederick W Muskett; Mariusz Muzylak; Kevin Greenslade; Adrian Moore; Li Zhang; Jianhua Gong; Xueming Qian; Chris Paszty; Richard J Taylor; Martyn K Robinson; Mark D Carr
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

Review 2.  Nerve growth factor modulation of the cavernous nerve response to injury.

Authors:  Anthony J Bella; Guiting Lin; Ching-Shwun Lin; Duane R Hickling; Christopher Morash; Tom F Lue
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

Review 3.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

Review 4.  Bone Morphogenetic Proteins.

Authors:  Takenobu Katagiri; Tetsuro Watabe
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

5.  A mutation in the receptor binding site of GDF5 causes Mohr-Wriedt brachydactyly type A2.

Authors:  K W Kjaer; H Eiberg; L Hansen; C B van der Hagen; K Rosendahl; N Tommerup; S Mundlos
Journal:  J Med Genet       Date:  2005-07-13       Impact factor: 6.318

6.  The H6D variant of NAG-1/GDF15 inhibits prostate xenograft growth in vivo.

Authors:  Xingya Wang; Kali Chrysovergis; Rachelle J Bienstock; Minsub Shim; Thomas E Eling
Journal:  Prostate       Date:  2011-08-01       Impact factor: 4.104

Review 7.  Structure-guided engineering of TGF-βs for the development of novel inhibitors and probing mechanism.

Authors:  Andrew P Hinck
Journal:  Bioorg Med Chem       Date:  2018-07-07       Impact factor: 3.641

8.  Adenovirus-mediated expression of growth and differentiation factor-5 promotes chondrogenesis of adipose stem cells.

Authors:  Gang Feng; Yuqing Wan; Gary Balian; Cato T Laurencin; Xudong Li
Journal:  Growth Factors       Date:  2008-06       Impact factor: 2.511

9.  Cytotoxic aggregation and amyloid formation by the myostatin precursor protein.

Authors:  Carlene S Starck; Andrew J Sutherland-Smith
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

10.  Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN.

Authors:  Petra Seemann; Anja Brehm; Jana König; Carsten Reissner; Sigmar Stricker; Pia Kuss; Julia Haupt; Stephanie Renninger; Joachim Nickel; Walter Sebald; Jay C Groppe; Frank Plöger; Jens Pohl; Mareen Schmidt-von Kegler; Maria Walther; Ingmar Gassner; Cristina Rusu; Andreas R Janecke; Katarina Dathe; Stefan Mundlos
Journal:  PLoS Genet       Date:  2009-11-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.